Loading...

European Continuous Glucose Monitoring Systems Market is Expected to Reach $792 Million, by 2022

 
 

quote Sensors govern majority of the European continuous glucose monitoring systems market due to the high frequency of usage, high cost, and disposable nature. At present, there is an increase in demand for non-invasive and wearable continuous glucose monitoring sensors, which will boost the sensors market in future, thereby driving the European continuous glucose monitoring systems market. quote

Pallavi Jaiswal

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

Europe Continuous Glucose Monitoring Systems Market Report, published by Allied Market Research, forecasts that the market was valued $58 million in 2015, and is expected to reach $792 million by 2022, supported by a CAGR of 44.9% during the forecast period 2016 - 2022. The sensors segment is anticipated to generate the highest revenue in this market during the forecast period.

The European CGMS market is expected to witness dynamic growth, owing to rise in per capita healthcare expenditure, increase in disposable income of individuals, and growth in prevalence rates of diabetes. In addition, CGMS has various advantages over conventional glucose monitors such as greater sensitivity, higher precision, and periodic monitoring. CGMS can be used across all age groups and various healthcare settings. Moreover, the technology is applicable in artificial/bionic pancreas; hence, several CGMS and insulin pump manufacturers focus on the development of novel and advanced CGMS. However, unfavorable reimbursement policies for CGMS hinder the market growth.

Sensors market contributed for the highest share of revenue in the CGMS market. In addition, the market is expected to witness the highest growth during the analysis period, as CGM sensors are changed frequently as compared to transmitters & receivers. As the percentage of adult population is high, this segment is estimated to generate the largest market revenue. However, owing to the growth in demand for CGM devices for children, the children population segment may grow at a higher CAGR.

Based on end-user market analysis, diagnostics/clinics contributed the highest share to the market revenue. The network of health insurers with the physicians operating at the diagnostics/clinics level is expected to drive the CGMS market in European diagnostics/clinics. However, high growth of the home healthcare segment is expected, as this segment is economic as compared to treatment from healthcare institutions. In addition, home healthcare would be the suitable solution for geriatric and children population who cannot visit the clinics for diabetes treatment.

Key findings of Europe Continuous Glucose Monitoring Systems Market:

  • UK is projected to grow at the highest CAGR during the forecast period.

  • Germany generated about one-fifth of the total market revenue in 2015, and is projected to be the maximum revenue-generating country by 2022.

  • Sensors segment accounted for more than three-fifths of the market revenue in 2015 and is projected to exhibit prominent growth during the forecast period.

  • Home healthcare and diagnostic/clinics contributed over half of the market share in 2015.

Region wise, Germany leads the market, in terms of revenue, owing to favorable guidelines about pricing and fixed reimbursement budget allocation for CGM devices. In addition, the market is estimated to exhibit significant growth in Norway, Sweden, and Denmark owing to the availability of advanced diabetes care facilities, and robust clinical guidelines and standards for diabetes management.

Renowned companies, such as Senseonics and Rubin Medical, have adopted collaboration as their key strategy to commercialize their CGMS products in Denmark and Sweden. An increasing number of diabetic patients, well-structured diabetes management regime, and proactive initiatives taken by the government have encouraged several CGMS companies to invest in Europe.

Key players profiled in this report include Abbott Laboratories, DexCom Inc., Echo Therapeutics Inc., Insulet Corporation, Johnson & Johnson, Medtronic plc, Senseonics Holding Inc., and F. Hoffmann-La Roche Ltd. Other players (not profiled in this report) operating in this market include AgaMatrix, Inc., GlySure, OrSense, and Ypsomed.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Europe Continuous Glucose Monitoring Systems Market by Component (Sensors, Transmitter & Receiver, and Integrated Insulin Pumps), Demographics (Adult Population and Child Population), and End User (Diagnostics, ICUs, and Home Healthcare) - Opportunity Analysis and Industry Forecast, 2014-2022 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"European Continuous Glucose Monitoring Systems Market"
Purchase Enquiry